Yang Yuting, Sun Xinghuai
Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia, Chinese Academy of Medical Sciences, and Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University, Shanghai, China.
Curr Eye Res. 2023 Jan;48(1):1-10. doi: 10.1080/02713683.2022.2068182. Epub 2022 May 25.
Retinal ganglion cell death occurs during the glaucoma pathological process, and it is significant because of the poor regeneration capacity of retinal ganglion cells. With a constantly increasing understanding of retinal cell death mechanisms, we now know that simply blocking a specific mechanism of cell death might not prevent retinal ganglion cell death. This review aimed to summarize the mechanisms of retinal cell death in glaucoma models and discuss the caveats in restoring visual function in these studies. A literature search was done on PubMed using key words including glaucoma, ocular hypertension, retinal ganglion cell, cell death, apoptosis, necroptosis, pyroptosis, ferroptosis, autophagic cell death, and parthanatos. The literature was reviewed to summarize the information about the lethal pathways of retinal ganglion cell in the glaucoma-like animal models. Based on the purpose, 100 studies were selected and discussed in this review. The damage to ganglion cells in glaucoma-like animals can occur via multiple lethal pathways and the molecular mechanisms are still incompletely understood. Further investigations on the crosstalk between different cell death pathways and the common upstream regulators could augment the development of novel targeting agents for the curative treatment of glaucoma.
视网膜神经节细胞死亡发生在青光眼病理过程中,由于视网膜神经节细胞再生能力差,这一现象具有重要意义。随着对视网膜细胞死亡机制的不断深入了解,我们现在知道,仅仅阻断特定的细胞死亡机制可能无法预防视网膜神经节细胞死亡。本综述旨在总结青光眼模型中视网膜细胞死亡的机制,并讨论这些研究中恢复视觉功能的注意事项。使用包括青光眼、高眼压、视网膜神经节细胞、细胞死亡、凋亡、坏死性凋亡、焦亡、铁死亡、自噬性细胞死亡和PARP-1依赖性细胞坏死等关键词在PubMed上进行文献检索。对文献进行综述,以总结青光眼样动物模型中视网膜神经节细胞致死途径的信息。基于此目的,本综述选择并讨论了100项研究。青光眼样动物中神经节细胞的损伤可通过多种致死途径发生,其分子机制仍未完全了解。对不同细胞死亡途径之间的相互作用以及共同上游调节因子的进一步研究,可能会促进新型靶向药物的开发,用于青光眼的治疗。